These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 32527506)
41. Knowledge and attitudes about pharmacotherapy for alcoholism: a survey of counselors and administrators in community-based addiction treatment centres. Thomas SE; Miller PM Alcohol Alcohol; 2007; 42(2):113-8. PubMed ID: 17172258 [TBL] [Abstract][Full Text] [Related]
42. Aripiprazole Suppression of Drinking in a Clinical Laboratory Paradigm: Influence of Impulsivity and Self-Control. Anton RF; Schacht JP; Voronin KE; Randall PK Alcohol Clin Exp Res; 2017 Jul; 41(7):1370-1380. PubMed ID: 28493623 [TBL] [Abstract][Full Text] [Related]
43. Perceptions about mindfulness-based interventions among individuals recovering from opioid and alcohol use disorders: Findings from focus groups. Jones KO; Lopes S; Chen L; Zhang L; Zinzow H; Jindal M; Mclain M; Shi L Complement Ther Med; 2019 Oct; 46():131-135. PubMed ID: 31519269 [TBL] [Abstract][Full Text] [Related]
44. Concurrent use of alcohol with other drugs and DSM-5 alcohol use disorder comorbid with other drug use disorders: Sociodemographic characteristics, severity, and psychopathology. Saha TD; Grant BF; Chou SP; Kerridge BT; Pickering RP; Ruan WJ Drug Alcohol Depend; 2018 Jun; 187():261-269. PubMed ID: 29689486 [TBL] [Abstract][Full Text] [Related]
45. Crazy'App: A web survey on representations and attitudes toward mental disorders using video testimonies. Morgiève M; N'Diaye K; Nguyen-Khac A; Mallet L; Briffault X Encephale; 2019 Sep; 45(4):290-296. PubMed ID: 30470498 [TBL] [Abstract][Full Text] [Related]
46. Opioid antagonists for alcohol dependence. Srisurapanont M; Jarusuraisin N Cochrane Database Syst Rev; 2005 Jan; (1):CD001867. PubMed ID: 15674887 [TBL] [Abstract][Full Text] [Related]
47. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Rounsaville B; Biol Psychiatry; 2005 May; 57(10):1128-37. PubMed ID: 15866552 [TBL] [Abstract][Full Text] [Related]
48. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions. Williams EC; Matson TE; Harris AHS Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686 [TBL] [Abstract][Full Text] [Related]
49. DSM-5 Alcohol Use Disorder Severity in Puerto Rico: Prevalence, Criteria Profile, and Correlates. Caetano R; Gruenewald P; Vaeth PAC; Canino G Alcohol Clin Exp Res; 2018 Feb; 42(2):378-386. PubMed ID: 29293264 [TBL] [Abstract][Full Text] [Related]
50. Perceived effectiveness of medications among mental health service users with and without alcohol dependence. Edlund MJ; Harris KM Psychiatr Serv; 2006 May; 57(5):692-9. PubMed ID: 16675765 [TBL] [Abstract][Full Text] [Related]
51. Identifying an accurate self-reported screening tool for alcohol use disorder: evidence from a Swiss, male population-based assessment. Baggio S; Trächsel B; Rousson V; Rothen S; Studer J; Marmet S; Heller P; Sporkert F; Daeppen JB; Gmel G; Iglesias K Addiction; 2020 Mar; 115(3):426-436. PubMed ID: 31656049 [TBL] [Abstract][Full Text] [Related]
52. Predictors of Daily Adherence to Naltrexone for Alcohol Use Disorder Treatment During a Mobile Health Intervention. Dermody SS; Wardell JD; Stoner SA; Hendershot CS Ann Behav Med; 2018 Aug; 52(9):787-797. PubMed ID: 30124761 [TBL] [Abstract][Full Text] [Related]
53. Brain Glutamate, GABA, and Glutamine Levels and Associations with Recent Drinking in Treatment-Naïve Individuals with Alcohol Use Disorder Versus Light Drinkers. Prisciandaro JJ; Schacht JP; Prescot AP; Renshaw PF; Brown TR; Anton RF Alcohol Clin Exp Res; 2019 Feb; 43(2):221-226. PubMed ID: 30537347 [TBL] [Abstract][Full Text] [Related]
54. The harmful dysfunction model of alcohol use disorder: revised criteria to improve the validity of diagnosis and prevalence estimates. Wakefield JC; Schmitz MF Addiction; 2015 Jun; 110(6):931-42. PubMed ID: 25622535 [TBL] [Abstract][Full Text] [Related]
55. Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study). Morley KC; Kranzler HR; Luquin N; Baillie A; Shanahan M; Trent R; Teesson M; Haber PS Trials; 2018 Aug; 19(1):443. PubMed ID: 30115121 [TBL] [Abstract][Full Text] [Related]
56. Views about responsibility for alcohol addiction and negative evaluations of naltrexone. Johnson RA; Lukens JM; Kole JW; Sisti DA Subst Abuse Treat Prev Policy; 2015 Mar; 10():10. PubMed ID: 25886539 [TBL] [Abstract][Full Text] [Related]
57. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram. Petrakis IL; Nich C; Ralevski E Schizophr Bull; 2006 Oct; 32(4):644-54. PubMed ID: 16887890 [TBL] [Abstract][Full Text] [Related]
59. Survey of Addiction Specialists' Use of Medications to Treat Alcohol Use Disorder. Ehrie J; Hartwell EE; Morris PE; Mark TL; Kranzler HR Front Psychiatry; 2020; 11():47. PubMed ID: 32116860 [TBL] [Abstract][Full Text] [Related]
60. Understanding alcohol use and changes in drinking habits among people with a severe mental illness: a qualitative framework analysis study. Puddephatt JA; Makin H; Gage SH; Jones A; Goodwin L Front Psychol; 2023; 14():1282086. PubMed ID: 38155700 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]